Denver Wealth Management Inc. Boosts Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Denver Wealth Management Inc. lifted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 0.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,779 shares of the exchange traded fund’s stock after purchasing an additional 127 shares during the quarter. SPDR S&P Biotech ETF accounts for approximately 0.7% of Denver Wealth Management Inc.’s holdings, making the stock its 24th biggest position. Denver Wealth Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,460,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of XBI. Fifth Third Bancorp raised its position in SPDR S&P Biotech ETF by 3.4% in the 2nd quarter. Fifth Third Bancorp now owns 118,303 shares of the exchange traded fund’s stock worth $10,968,000 after buying an additional 3,922 shares during the last quarter. RFG Advisory LLC purchased a new position in SPDR S&P Biotech ETF in the 1st quarter worth about $219,000. Avantax Advisory Services Inc. raised its position in SPDR S&P Biotech ETF by 17.2% in the 1st quarter. Avantax Advisory Services Inc. now owns 9,619 shares of the exchange traded fund’s stock worth $913,000 after buying an additional 1,415 shares during the last quarter. PFG Investments LLC raised its position in SPDR S&P Biotech ETF by 9.2% in the 2nd quarter. PFG Investments LLC now owns 24,844 shares of the exchange traded fund’s stock worth $2,303,000 after buying an additional 2,097 shares during the last quarter. Finally, Brookstone Capital Management purchased a new position in SPDR S&P Biotech ETF in the 1st quarter worth about $284,000.

SPDR S&P Biotech ETF Trading Down 1.7 %

NYSEARCA:XBI traded down $1.73 during mid-day trading on Monday, reaching $98.10. The company’s stock had a trading volume of 4,488,389 shares, compared to its average volume of 9,460,941. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52. The firm’s fifty day moving average price is $99.08 and its two-hundred day moving average price is $94.37. The stock has a market cap of $7.48 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.